MattioliAV. Effects of caffeine and coffee consumption on cardiovascular disease and risk factors. Future Cardiol. 2007; 3:203–212.
2.
GacheL, Almeida-de-SouzaJ. Systematic review of the effects of coffee or its components on platelets and their regulators. J Caffeine Adenosine. 2021 (in press).
3.
CheungRJ, GuptaEK, ItoMK. Acute coffee ingestion does not affect LDL cholesterol level. Ann Pharmacother. 2005; 39:1209–1213.
4.
TruzziML, Ballerini PuvianiM, TripodiA, et al.Mediterranean diet as a model of sustainable, resilient and healthy diet. Prog Nutr. 2020; 22:388–394.
5.
WoodwardM, Tunstall-PedoeH. Coffee and tea consumption in the Scottish Heart Health Study follow-up: Conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health. 1999; 53:481–487.
6.
MattioliAV, MigaldiM, FarinettiA. Coffee in hypertensive women with asymptomatic peripheral arterial disease: A potential nutraceutical effect. J Cardiovasc Med (Hagerstown). 2018; 19:183–185.
7.
HutachokN, AngkasithP, ChumpunC, et al. Anti-platelet aggregation and anti-cyclooxygenase activities for a range of coffee extracts (Coffea arabica). Molecules. 2020; 26:10.
8.
MattioliAV, SciomerS, MoscucciF, et al. Cardiovascular prevention in women: A narrative review from the Italian Society of Cardiology working groups on ‘cardiovascular prevention, hypertension and peripheral circulation’ and on ‘women disease.’ J Cardiovasc Med. 2019; 20:575–583.
9.
SirotkinAV, KolesárováA. The anti-obesity and health-promoting effects of tea and coffee. Physiol Res. 2021; 70:161–168.
10.
PurdyJC, ShatzelJJ. The hematologic consequences of obesity. Eur J Haematol. 2021; 106:306–319.
